(PRWEB) November 7, 2004
As the aging population expands, more women than ever before are suffering from stress or urge incontinence. Through increased awareness and greater education, however, these women are overcoming their embarrassment and are stepping forward to receive new treatments, such as fixationless vaginal slings. According to new reports by Millennium Research Group (MRG), over 195,000 fixationless vaginal sling procedures have been performed this year in the US, Europe, and Japan for the treatment of female incontinence. By 2009, the global fixationless vaginal sling market will generate over $240 million in revenue.
Gynecare, a division of Johnson & JohnsonÂs (JNJ) Ethicon subsidiary, was the first to introduce fixationless vaginal slings worldwide. These highly effective products re-establish support for the bladder and bladder neck, allowing women to retain their urine. Since the introduction of GynecareÂs Tension-free Vaginal Tape (TVT), over 10 competing fixationless vaginal sling products have been introduced, and innovation has continued with the most recent advance of the transobturator approach. Transobturator vaginal slings offer the potential of an even less invasive approach than the original fixationless sling designs. This and other innovations will drive fixationless vaginal sling markets worldwide.
The US, European, and Japanese fixationless vaginal sling markets are included in MRGÂs Global Markets for Urological Devices 2004 series. The global report series details over 90 competitors, including American Medical Systems (AMMD), Boston Scientific (BSX), Cook Urological, C.R. Bard (BCR), Gynecare (JNJ), Karl Storz, Mentor Medical Systems (MNT), and Olympus (OCPNY).
A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.
Millennium Research Group Inc.,
(416) 364-7776 ext. 122